Cargando…
Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer
INTRODUCTION: Non-small cell lung cancer (NSCLC) is the leading cause of cancer incidence and mortality worldwide. Neoadjuvant chemo-immunotherapy has led to clinical benefits in resectable NSCLC in comparison to chemo-therapy alone. Major pathological response (MPR) and pathological complete respon...
Autores principales: | Alì, Greta, Poma, Anello Marcello, Di Stefano, Iosè, Zirafa, Carmelina Cristina, Lenzini, Alessandra, Martinelli, Giulia, Romano, Gaetano, Chella, Antonio, Baldini, Editta, Melfi, Franca, Fontanini, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947557/ https://www.ncbi.nlm.nih.gov/pubmed/36845706 http://dx.doi.org/10.3389/fonc.2023.1115156 |
Ejemplares similares
-
New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
por: Di Stefano, Iosè, et al.
Publicado: (2023) -
Prevalence of Delta-Like Protein 3 in a Consecutive Series of Surgically Resected Lung Neuroendocrine Neoplasms
por: Alì, Greta, et al.
Publicado: (2021) -
Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers
por: Bruno, Rossella, et al.
Publicado: (2022) -
SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas
por: Panozzi, Martina, et al.
Publicado: (2023) -
Robotic versus Open Surgery in Locally Advanced Non-Small Cell Lung Cancer: Evaluation of Surgical and Oncological Outcomes
por: Zirafa, Carmelina C., et al.
Publicado: (2023)